Rx Labeling Rule Will Be Final Soon; Warnings & Precautions To Be Merged
Executive Summary
FDA plans to eliminate the distinction between "Warnings" and "Precautions" as part of its labeling rewrite rule, Office of New Drugs acting Director Sandra Kweder told the Senate Finance Committee Nov. 18
You may also be interested in...
DailyMed E-Labeling System Completion Awaits Physician Label Final Rule
The "DailyMed" electronic labeling system will be implemented in November; however, up-to-date information will not be fully available for roughly one year, FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb said Sept. 28
DailyMed E-Labeling System Completion Awaits Physician Label Final Rule
The "DailyMed" electronic labeling system will be implemented in November; however, up-to-date information will not be fully available for roughly one year, FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb said Sept. 28
Antihypertensive Cardio Labeling Should Be Applied To New Classes – Cmte.
Class labeling for reduction of cardiovascular outcomes based on blood pressure lowering should be applied to new classes of antihypertensives, members of FDA's Cardiovascular & Renal Drugs Advisory Committee said